A Case Report of Unresectable Cutaneous Squamous Cell Carcinoma Responsive to Pembrolizumab, a Programmed Cell Death Protein 1 Inhibitor

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA dermatology (Chicago, Ill.) Ill.), 2016-01, Vol.152 (1), p.106-108
Hauptverfasser:	Chang, Anne Lynn S, Kim, Jinah, Luciano, Richard, Sullivan-Chang, Loretta, Colevas, Alexander D
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal, Humanized - pharmacology Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - pathology Humans Male Programmed Cell Death 1 Receptor - antagonists & inhibitors Skin Neoplasms - drug therapy Skin Neoplasms - pathology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!